8-K//Current report
Estrella Immunopharma, Inc. 8-K
Accession 0001213900-25-107249
$ESLACIK 0001844417operating
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 5:17 PM ET
Size
261.2 KB
Accession
0001213900-25-107249
Documents
- 8-Kea0264099-8k_estrella.htmPrimary
CURRENT REPORT
- EX-99.1ea026409901ex99-1_estrella.htm
PRESS RELEASE ISSUED BY ESTRELLA IMMUNOPHARMA, INC., DATED NOVEMBER 3, 2025
- EX-101.SCHesla-20251103.xsd
XBRL SCHEMA FILE
- EX-101.DEFesla-20251103_def.xml
XBRL DEFINITION FILE
- EX-101.LABesla-20251103_lab.xml
XBRL LABEL FILE
- EX-101.PREesla-20251103_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-107249-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0264099-8k_estrella_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Estrella Immunopharma, Inc.
CIK 0001844417
Entity typeoperating
Related Parties
1- filerCIK 0001844417
Filing Metadata
- Form type
- 8-K
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 5:17 PM ET
- Size
- 261.2 KB